Complications and corrections of lipoplasty

Published on 22/05/2015 by admin

Filed under Plastic Reconstructive Surgery

Last modified 22/05/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1401 times

CHAPTER 60 Complications and corrections of lipoplasty

History

Since the beginning of the 20th century many surgeons have tried to model body contouring to fit the current concept of beauty of the time. Historically, many approaches have been used to evacuate fat deposits during lipoplasty, and some of these procedures had complications.

Dujarrier first attempted to remove subcutaneous fat with a uterine curette, but tragic complications eventually evolved to necrosis and amputation, possibly due to vascular injury or infection.2 It was the first complication described for a lipoplasty attempt.

No technical innovations were achieved until 1982, when Joseph Schrudde used a delicate curette to correct lipodystrophy, significantly reducing blood loss.3

The senior author was one of the pioneers of the careful approach of the superficial layer of the abdomen which was, before this, responsible for many contour irregularities, as a consequence of treatment of the deeper layer. The same author included the back region and, progressively, included other areas, noting significant retraction of the skin and a better contour. He also observed that, with no superficial approach, it was difficult to obtain good results in the presence of scars or depressions.4 It was Gasparotti5 who named this technique “superficial liposuction” and promoted it internationally. The development of new techniques, new cannulas, better anesthesia and the better training of the surgeon are helping to ensure patients’ safety and the efficacy of the procedure.

Complications

See Table 60.1.

Table 60.1 Factors that increase risk in lipoplasty

1. Injecting too much fluid and local anesthesia
2. Removing too much fat
3. Performing too many procedures in the same surgical act
4. Wrong indication for the procedure
5. Inadequate monitoring

*Grazer FM, de Jong RH. Fatal Outcomes from liposuction: census survey of cosmetic surgeons. Plast Reconstr Surg 2000;105:436–446.

The complications of lipoplasty can be local (aesthetic complications) or systemic (life-threatening complications).

The local complications can be irregularities, depressions, seromas, hematomas, alterations of skin color and sensitivity, infections, excess skin and cutaneous necrosis, cutis marmorata. The systemic issues are deep venous thrombosis, pulmonary embolism, fat emboli, hypovolemia, edema, toxicity or medication interaction, perforation of viscera, sepsis and other complications associated with any surgical procedure.

Unsatisfactory results in cases where ideal contour is not achieved, may be either due to undercorrection, asymmetrical correction or failure in communication between the patient and surgeon.

Liposuction is a very common procedure, and is performed by dermatologists, gynecologists, otolaryngologists and others. The practice of lipoplasty by non-trained professionals who perform this procedure in a place without necessary hospital support, predisposes patients to complications with potentially fatal outcomes.

Lidocaine and adrenaline toxicity

The FDA defines 7 mg/kg as the maximum safe dose of lidocaine with epinephrine (and 5 mg/kg for lidocaine only) for regional anesthesia. Literature on liposuction reports the use of lidocaine in doses of up to 33–35 mg/kg,1 but always in solutions with adrenaline and with low concentration of lidocaine (0.1%) in large volume infiltration. Since the subcutaneous area is able to retain lidocaine, it is be restricted to the infiltration site, and only the exceeding molecules (1 mg of lidocaine for 1 g of tissue) would be available to be submitted to conventional pharmacokinetics. Hepatic function is an important factor that interferes in the concentration of lidocaine. Even drugs which interact with lidocaine in the hepatic cytochromes, such as antidepressants, might raise the serum concentration of lidocaine, causing signs of toxicity in the central nervous and cardiac systems. The hepatic metabolization of lidocaine and adrenaline reaches its serum peak within three hours after infiltration, returning to normal values after 12 hours.6

The excessive infiltration of solutions with lidocaine can cause toxicity, cardiotoxicity, convulsions, drug interaction and overdose.

Buy Membership for Plastic Reconstructive Surgery Category to continue reading. Learn more here